HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA075640 (QUAGEN)
HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA Approval ANDA075640 (QUAGEN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; Application number: ANDA075640.
| Brand name | HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE |
| Application number | ANDA075640 |
| Sponsor | QUAGEN |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20000128 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →